文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

急性胰腺炎重症监护患者的胸段硬膜外镇痛:EPIPAN多中心随机对照试验

Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial.
PubMed 文献 · Crit Care · 2023-05-31
一句话结论在插管需求低的ICU急性胰腺炎成人中,胸段硬膜外镇痛加常规治疗未改善30天无呼吸机天数,且与有创通气时间延长相关。

EPIPAN是一项多中心、开放标签、随机对照试验,纳入ICU成人急性胰腺炎患者148例,135例进入意向治疗分析(干预组65例、对照组70例),比较胸段硬膜外镇痛联合常规治疗与单纯常规治疗。主要终点随机化至第30天无呼吸机天数两组无显著差异(中位数30天[15-30] vs 30天[18-30],中位绝对差-0.0天,95%CI -3.3至3.3,p=0.59)。硬膜外镇痛与有创通气时间延长显著相关(中位数14天[5-28] vs 6天[2-13],p=0.02)。作者结论:这一首个多中心随机试验未显示胸段硬膜外镇痛加常规治疗的预期获益,该条件下硬膜外镇痛的安全性需进一步研究。

要点

  • 插管需求低的ICU急性胰腺炎成人中,胸段硬膜外镇痛加常规治疗未增加30天无呼吸机天数:中位数30天[15-30] vs 30天[18-30],中位绝对差-0.0天(95%CI -3.3至3.3,p=0.59)。
  • 硬膜外镇痛组有创通气时间更长:中位数14天[5-28] vs 对照组6天[2-13],p=0.02。
  • 该试验为多中心、开放标签、随机对照设计,148例入组、135例纳入意向治疗分析(干预组65例、对照组70例)。
  • 作者结论:未显示胸段硬膜外镇痛加常规治疗的预期获益,该条件下硬膜外镇痛的安全性需进一步研究。

适用人群与场景

  • 入住ICU的成人急性胰腺炎患者(临床诊断),随机分组前插管需求低;排除标准原文未列出。

处置流程与药物剂量

  • 干预组:胸段硬膜外镇痛联合常规治疗;对照组:单纯常规治疗;硬膜外镇痛的具体药物、剂量、给药方案原文未写明。

研究设计与关键结果

  • 研究类型:多中心、开放标签、随机对照试验;2014年6月至2019年1月入组148例,135例纳入意向治疗分析(干预组65例、对照组70例)。
  • 主要终点:随机化至第30天无呼吸机天数两组无显著差异,干预组中位数30天[15-30] vs 对照组30天[18-30],中位绝对差-0.0天(95%CI -3.3至3.3,p=0.59)。
  • 关键次要终点:硬膜外镇痛与有创通气时间延长显著相关,干预组中位数14天[5-28] vs 对照组6天[2-13],p=0.02。

证据类型、等级与局限

  • 证据类型:多中心、开放标签、随机对照试验(EPIPAN)。
  • 局限:作者指出该条件下硬膜外镇痛的安全性需进一步研究。

对床旁实践的改变

  • 在插管需求低的ICU急性胰腺炎成人中,作者认为胸段硬膜外镇痛加常规治疗未显示预期的无呼吸机天数获益,且与有创通气时间延长相关;该条件下硬膜外镇痛的安全性需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Findings from preclinical studies and one pilot clinical trial suggest potential benefits of epidural analgesia in acute pancreatitis. We aimed to assess the efficacy of thoracic epidural analgesia, in addition to usual care, in improving clinical outcomes of intensive care unit patients with acute pancreatitis.

METHODS: A multicenter, open-label, randomized, controlled trial including adult patients with a clinical diagnosis of acute pancreatitis upon admission to the intensive care unit. Participants were randomly assigned (1:1) to a strategy combining thoracic epidural analgesia and usual care (intervention group) or a strategy of usual care alone (control group). The primary outcome was the number of ventilator-free days from randomization until day 30.

RESULTS: Between June 2014 and January 2019, 148 patients were enrolled, and 135 patients were included in the intention-to-treat analysis, with 65 patients randomly assigned to the intervention group and 70 to the control group. The number of ventilator-free days did not differ significantly between the intervention and control groups (median [interquartile range], 30 days [15-30] and 30 days [18-30], respectively; median absolute difference of - 0.0 days, 95% CI - 3.3 to 3.3; p = 0.59). Epidural analgesia was significantly associated with longer duration of invasive ventilation (median [interquartile range], 14 days [5-28] versus 6 days [2-13], p = 0.02).

CONCLUSIONS: In a population of intensive care unit adults with acute pancreatitis and low requirement for intubation, this first multicenter randomized trial did not show the hypothesized benefit of epidural analgesia in addition to usual care. Safety of epidural analgesia in this setting requires further investigation.

TRIAL REGISTRATION: ClinicalTrials.gov registration number NCT02126332 , April 30, 2014.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Jabaudon M, Genevrier A, Jaber S, et al. Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial. Crit Care. 2023. PMID: 37259157. doi:10.1186/s13054-023-04502-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。